| Product Code: ETC6176413 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Australia Cannabis Medicine Market Overview |
3.1 Australia Country Macro Economic Indicators |
3.2 Australia Cannabis Medicine Market Revenues & Volume, 2021 & 2031F |
3.3 Australia Cannabis Medicine Market - Industry Life Cycle |
3.4 Australia Cannabis Medicine Market - Porter's Five Forces |
3.5 Australia Cannabis Medicine Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 Australia Cannabis Medicine Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Australia Cannabis Medicine Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Australia Cannabis Medicine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness and acceptance of medical cannabis for various health conditions in Australia |
4.2.2 Growing research and development activities to explore the therapeutic benefits of cannabis medicine |
4.2.3 Favorable regulatory environment and legalization of medical cannabis in Australia |
4.3 Market Restraints |
4.3.1 Limited access to medical cannabis due to strict regulations and licensing requirements |
4.3.2 High costs associated with medical cannabis products and treatments |
4.3.3 Lack of standardized dosing guidelines and clinical evidence for cannabis medicine |
5 Australia Cannabis Medicine Market Trends |
6 Australia Cannabis Medicine Market, By Types |
6.1 Australia Cannabis Medicine Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 Australia Cannabis Medicine Market Revenues & Volume, By Product Type, 2021- 2031F |
6.1.3 Australia Cannabis Medicine Market Revenues & Volume, By Prescription Drugs, 2021- 2031F |
6.1.4 Australia Cannabis Medicine Market Revenues & Volume, By Recreational Drugs, 2021- 2031F |
6.2 Australia Cannabis Medicine Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Australia Cannabis Medicine Market Revenues & Volume, By Chronic Pain, 2021- 2031F |
6.2.3 Australia Cannabis Medicine Market Revenues & Volume, By Mental Disorders, 2021- 2031F |
6.2.4 Australia Cannabis Medicine Market Revenues & Volume, By Cancer, 2021- 2031F |
6.3 Australia Cannabis Medicine Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 Australia Cannabis Medicine Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.3.3 Australia Cannabis Medicine Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.3.4 Australia Cannabis Medicine Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
7 Australia Cannabis Medicine Market Import-Export Trade Statistics |
7.1 Australia Cannabis Medicine Market Export to Major Countries |
7.2 Australia Cannabis Medicine Market Imports from Major Countries |
8 Australia Cannabis Medicine Market Key Performance Indicators |
8.1 Number of clinical trials and research studies conducted on cannabis medicine in Australia |
8.2 Patient satisfaction and reported health outcomes after using medical cannabis |
8.3 Number of healthcare professionals trained in prescribing and administering cannabis-based treatments |
9 Australia Cannabis Medicine Market - Opportunity Assessment |
9.1 Australia Cannabis Medicine Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 Australia Cannabis Medicine Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Australia Cannabis Medicine Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Australia Cannabis Medicine Market - Competitive Landscape |
10.1 Australia Cannabis Medicine Market Revenue Share, By Companies, 2024 |
10.2 Australia Cannabis Medicine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here